New data reveals optimal timing for percutaneous coronary intervention in TAVR patients

FHS
May 4, 2024
3:40 am

New data reveals that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery disease (CAD).

SLS Europe and Bilthoven Biologicals receive positive CHMP Opinion for SIILTIBCY – a novel Tuberculosis Skin Test in Europe – Biotech Investments

EQS-News: Serum Life Science Europe GmbH / Key word(s): Regulatory Approval/Preliminary Results SLS Europe and Bilthoven Biologicals receive positive CHMP Opinion for SIILTIBCY – a

October 24, 2024

New method revolutionizes DNA-encoded chemical libraries

Nowadays, there’s lots of buzz about spectacular new medical treatments such as personalised cancer therapy with modified immune cells or antibodies.

September 2, 2024

Bayer details data from two Phase 3 trial wins for menopause symptom drug

Bayer shared more data on its menopause symptom drug elinzanetant, which demonstrates how the treatment triumphed over placebo in two of three Phase 3 trials.

May 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.